Inovio Pharmaceuticals, Inc.
Symbol: INO (NASDAQ)
1.90
▲ (16.98%) 0.275
Company Description:
Inovio Pharmaceuticals Inc is a United States-based biotechnology company. The company is focused on developing and commercializing DNA medicines to help treat and protect people from HPV-associated diseases, cancer and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.
Key Stats
- Today's Open: $1.75
- Today's High: $2.074
- Today's Low: $1.655
- Today's Volume: 11.67M
- Yesterday Close: $1.62
- Yesterday High: $1.6777
- Yesterday Low: $1.58
- Yesterday Volume: 1.09M
- Last Min Volume: 7
- Last Min High: $1.895
- Last Min Low: $1.891
- Last Min VWAP: $1.89443
Company Profile
- Name: Inovio Pharmaceuticals, Inc.
- Website: https://www.inovio.com
- Listed Date: 1998-12-08
- Location: PLYMOUTH MEETING, PA
- Market Status: Active
- CIK Number: 0001055726
- SIC Code: 2834
- SIC description: PHARMACEUTICAL PREPARATIONS
- Market Cap: $86.09M
- Round Lot: 100
- Outstanding Shares: 53.14M
- Asset Type: CS
RECENT FILINGS FOR INO
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-08-12 | 8-K | View |
| 2025-08-12 | 10-Q | View |
| 2025-07-17 | SCHEDULE 13G/A | View |
| 2025-07-07 | 8-K | View |
| 2025-07-03 | 424B5 | View |
| 2025-07-02 | 424B5 | View |
| 2025-07-01 | 4 | View |
| 2025-05-22 | 8-K | View |
| 2025-05-21 | 4 | View |
| 2025-05-21 | 4 | View |
| 2025-05-21 | 4 | View |
| 2025-05-21 | 4 | View |
| 2025-05-21 | 4 | View |
| 2025-05-21 | 4 | View |
| 2025-05-21 | 4 | View |
| 2025-05-21 | 4 | View |
| 2025-05-21 | 4 | View |
| 2025-05-21 | 4 | View |
| 2025-05-21 | 4 | View |
| 2025-05-16 | 4 | View |
Latest News on INO